Aboli Rane

Aboli Rane, PhD began their work experience as a Fellow in the Howard Hughes Medical Institute Med-to-Grad Program in 2009. From 2007 to 2012, they worked at UC San Diego as a PhD candidate in Biomaterial and Regenerative Medicine, where they conducted research on injectable biomaterials and their impact on cardiac function. After completing their PhD, they joined Illumina in 2012 as a Senior Product Engineer, where they led a team in maintaining product quality and yield. Aboli then held roles as Product Manager and Sr. Product Manager, working on the NovaSeq platform and genetic disease segments. From 2018 to 2022, they served as Sr. Manager of Segment Marketing at Illumina. In 2022, they joined Oxford Nanopore Technologies as the Director of Clinical Segment Marketing.

Aboli Rane, PhD has a Bachelor of Science degree in Chemical and Bio-molecular Engineering with a minor in Biomedical Engineering from Cornell University. Aboli then pursued further education at UC San Diego, where they earned a Ph.D in Bioengineering. In 2019, they attended Marketing Week Mini MBA with Mark Ritson, where they obtained a Mini MBA in Marketing.